Literature DB >> 16416209

Risk factors and ultrasound can predict chronic hepatitis caused by nonalcoholic fatty liver disease.

Thomas R Riley1, Amin Kahn.   

Abstract

The diagnosis of nonalcoholic fatty liver disease (NAFLD) is under-recognized. The aim of this study was to develop a scoring system that separates NAFLD diagnosis as a cause of chronic hepatitis from controls by using clinical features and liver ultrasound. A retrospective review of consecutive NAFLD cases and other liver disease controls was undertaken selecting patients from an abnormal liver function test code. To qualify for analysis all patients had to have elevated liver injury tests for more then 6 months, a biopsy-confirmed diagnosis, and an ultrasound as part of the evaluation. There were 84 cases of NAFLD and 75 liver disease controls. The NAFLD group had a larger body mass index (BMI) (34.9 versus 26.1; P < or = 0.0001), a larger liver span (9.8 versus 8.1 cm; P < or = 0.0001), and higher triglycerides (252 versus 142.6; P < or = 0.0001). The ultrasound reports recorded features consistent with fatty infiltration in 65.5% of NAFLD cases, compared to 5.3% of other liver diseases (P < or = 0.0001). Diabetes mellitus was found in 35% of NAFLD and 6.7% of other cases (P < or = 0.0001). The BMI was >30 in 79.8% of NAFLD cases and 22.7% of other liver disease cases (P < or = 0.0001). The liver span was >8 cm in 78.6% of NAFLD cases and in only 16% of controls (P = 0.0001). On multivariate analysis using logistic regression, the odds ratio of having ultrasound report findings suggestive of fatty infiltration was 15.9 (CI, 4.1-60). The odds ratio was 9.4 (CI, 2.3-37.9) for diabetes, 5.0 (CI, 1.7-14.6) for BMI >30, and 2.3 for liver span >8 cm (CI, 1.36-3.90). A scoring system using clinical features and ultrasound was shown to reliably separate NAFLD from other cases of chronic hepatitis.

Entities:  

Mesh:

Year:  2006        PMID: 16416209     DOI: 10.1007/s10620-006-3082-6

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  9 in total

Review 1.  Nonalcoholic fatty liver disease: an agenda for clinical research.

Authors:  Zobair M Younossi; Anna Mae Diehl; Janus P Ong
Journal:  Hepatology       Date:  2002-04       Impact factor: 17.425

2.  Liver fibrosis in overweight patients.

Authors:  V Ratziu; P Giral; F Charlotte; E Bruckert; V Thibault; I Theodorou; L Khalil; G Turpin; P Opolon; T Poynard
Journal:  Gastroenterology       Date:  2000-06       Impact factor: 22.682

Review 3.  Preventive strategies in chronic liver disease: part II. Cirrhosis.

Authors:  T R Riley; A M Bhatti
Journal:  Am Fam Physician       Date:  2001-11-15       Impact factor: 3.292

4.  Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity.

Authors:  C A Matteoni; Z M Younossi; T Gramlich; N Boparai; Y C Liu; A J McCullough
Journal:  Gastroenterology       Date:  1999-06       Impact factor: 22.682

5.  Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions.

Authors:  E M Brunt; C G Janney; A M Di Bisceglie; B A Neuschwander-Tetri; B R Bacon
Journal:  Am J Gastroenterol       Date:  1999-09       Impact factor: 10.864

Review 6.  Nonalcoholic steatohepatitis.

Authors:  B A Neuschwander-Tetri; B R Bacon
Journal:  Med Clin North Am       Date:  1996-09       Impact factor: 5.456

7.  Is ultrasonography useful in the assessment of diffuse parenchymal liver disease?

Authors:  N L Sanford; P Walsh; C Matis; H Baddeley; L W Powell
Journal:  Gastroenterology       Date:  1985-07       Impact factor: 22.682

8.  Clinical and histologic spectrum of nonalcoholic fatty liver disease associated with normal ALT values.

Authors:  Pouneh Mofrad; Melissa J Contos; Mahmadul Haque; Carol Sargeant; Robert A Fisher; Velimir A Luketic; Richard K Sterling; Mitchell L Shiffman; Richard T Stravitz; Arun J Sanyal
Journal:  Hepatology       Date:  2003-06       Impact factor: 17.425

9.  Validation of scoring system for diagnosis of autoimmune hepatitis.

Authors:  A Czaja; H A Carpenter
Journal:  Dig Dis Sci       Date:  1996-02       Impact factor: 3.199

  9 in total
  6 in total

1.  Bedside ultrasound can predict nonalcoholic fatty liver disease in the hands of clinicians using a prototype image.

Authors:  Thomas R Riley; Alfredo Mendoza; Michael A Bruno
Journal:  Dig Dis Sci       Date:  2006-06-17       Impact factor: 3.199

2.  Sonographic fatty liver and hepatitis B virus carrier status: synergistic effect on liver damage in Taiwanese adults.

Authors:  Yu-Cheng Lin; Shu-Tin Hsiao; Jong-Dar Chen
Journal:  World J Gastroenterol       Date:  2007-03-28       Impact factor: 5.742

3.  Body composition, C-reactive protein, carotid artery remodeling and subclinical atherosclerosis in a general Taiwanese population.

Authors:  Jui-Peng Tsai; Helen L Po; Chih-Hsuan Yen; Charles Jia-Yin Hou; Jen-Yuan Kuo; Chung-Lieh Hung
Journal:  J Thromb Thrombolysis       Date:  2012-02       Impact factor: 2.300

Review 4.  Bedside ultrasound in the diagnosis of nonalcoholic fatty liver disease.

Authors:  Nancy Khov; Amol Sharma; Thomas R Riley
Journal:  World J Gastroenterol       Date:  2014-06-14       Impact factor: 5.742

Review 5.  MRI and MRE for non-invasive quantitative assessment of hepatic steatosis and fibrosis in NAFLD and NASH: Clinical trials to clinical practice.

Authors:  Parambir S Dulai; Claude B Sirlin; Rohit Loomba
Journal:  J Hepatol       Date:  2016-06-14       Impact factor: 25.083

6.  Liver Fat, Hepatic Enzymes, Alkaline Phosphatase and the Risk of Incident Type 2 Diabetes: A Prospective Study of 132,377 Adults.

Authors:  Sean Chun-Chang Chen; Shan Pou Tsai; Jing-Yun Jhao; Wun-Kai Jiang; Chwen Keng Tsao; Ly-Yun Chang
Journal:  Sci Rep       Date:  2017-07-05       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.